Tempest Therapeutics


Tempest Therapeutics is a clinical-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways.


Org chart

Stephen Brady
President & CEO
Collapse
Nicholas Maestas
VP, Strategy & Finance
Justin Trojanowski, CPA
Corporate Controller
Darrin Bomba
VP, Clinical Operations

Board & advisors

Mike Raab
Chairman, Board of Directors
Ronit Simantov
Board Member
Geoff Nichol
Board Member


Offices